{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:39:21Z","timestamp":1781307561908,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03399-3","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T22:01:42Z","timestamp":1686175302000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between TSH and free thyroxine in outpatient cancer patient population"],"prefix":"10.1007","volume":"82","author":[{"given":"Hussam","family":"Alkhalaileh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K. Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnna","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-2578","authenticated-orcid":false,"given":"Jieli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"Apr","key":"3399_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"R. Mullur, Y.-Y. Liu, G.A. Brent, Thyroid hormone regulation of metabolism. Physiol. Rev. 94(Apr), 355\u2013382 (2014). https:\/\/doi.org\/10.1152\/physrev.00030.2013","journal-title":"Physiol. Rev."},{"issue":"Sep","key":"3399_CR2","doi-asserted-by":"publisher","first-page":"4106816","DOI":"10.1155\/2019\/4106816","volume":"2019","author":"S Razvi","year":"2019","unstructured":"S. Razvi, S. Bhana, S. Mrabeti, Challenges in interpreting thyroid stimulating hormone results in the diagnosis of thyroid dysfunction. J. Thyroid Res. 2019(Sep), 4106816 (2019). https:\/\/doi.org\/10.1155\/2019\/4106816","journal-title":"J. Thyroid Res."},{"issue":"Jan","key":"3399_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/105072503321086962","volume":"13","author":"Z Baloch","year":"2003","unstructured":"Z. Baloch, P. Carayon, B. Conte-Devolx et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13(Jan), 3\u2013126 (2003). https:\/\/doi.org\/10.1089\/105072503321086962","journal-title":"Thyroid"},{"issue":"Feb","key":"3399_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1530\/EJE-09-0655","volume":"162","author":"N Benhadi","year":"2010","unstructured":"N. Benhadi, E. Fliers, T.J. Visser, J.B. Reitsma, W.M. Wiersinga, Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. Eur. J. Endocrinol. 162(Feb), 323\u2013329 (2010). https:\/\/doi.org\/10.1530\/EJE-09-0655","journal-title":"Eur. J. Endocrinol."},{"issue":"Jul","key":"3399_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2265.1993.tb01758.x","volume":"39","author":"CA Meier","year":"1993","unstructured":"C.A. Meier, M.N. Maisey, A. Lowry, J. M\u00fcller, M.A. Smith, Interindividual differences in the pituitary-thyroid axis influence the interpretation of thyroid function tests. Clin. Endocrinol. (Oxf) 39(Jul), 101\u2013107 (1993). https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb01758.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Mar","key":"3399_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1210\/jc.2015-4011","volume":"101","author":"KM Rothacker","year":"2016","unstructured":"K.M. Rothacker, S.J. Brown, N.C. Hadlow, R. Wardrop, J.P. Walsh, Reconciling the log-linear and non-log-linear nature of the TSH-Free T4 relationship: intra-individual analysis of a large population. J. Clin. Endocrinol. Metab. 101(Mar), 1151\u20131158 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Jul","key":"3399_CR7","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1210\/jc.2012-4223","volume":"98","author":"NC Hadlow","year":"2013","unstructured":"N.C. Hadlow, K.M. Rothacker, R. Wardrop, S.J. Brown, E.M. Lim, J.P. Walsh, The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex. J. Clin. Endocrinol. Metab. 98(Jul), 2936\u20132943 (2013). https:\/\/doi.org\/10.1210\/jc.2012-4223","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Jul","key":"3399_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/EJE-16-0007","volume":"175","author":"D Strich","year":"2016","unstructured":"D. Strich, G. Karavani, S. Edri, D. Gillis, TSH enhancement of FT4 to FT3 conversion is age dependent. Eur. J. Endocrinol. 175(Jul), 49\u201354 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0007","journal-title":"Eur. J. Endocrinol."},{"issue":"Aug","key":"3399_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.12222","volume":"79","author":"M Wilmar","year":"2013","unstructured":"M. Wilmar, Wiersinga. Smoking and thyroid. Clin. Endocrinol. (Oxf) 79(Aug), 145\u2013151 (2013). https:\/\/doi.org\/10.1111\/cen.12222","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Jan","key":"3399_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1634\/theoncologist.2013-0237","volume":"19","author":"Y Carter","year":"2014","unstructured":"Y. Carter, R.S. Sippel, H. Chen, Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management. Oncologist. 19(Jan), 34\u201343 (2014). https:\/\/doi.org\/10.1634\/theoncologist.2013-0237","journal-title":"Oncologist."},{"issue":"Jul","key":"3399_CR11","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1016\/j.bbagen.2012.04.002","volume":"1830","author":"WG Kim","year":"2013","unstructured":"W.G. Kim, S.-yann Cheng, Thyroid hormone receptors and cancer. Biochim. Biophys. Acta 1830(Jul), 3928\u20133936 (2013). https:\/\/doi.org\/10.1016\/j.bbagen.2012.04.002","journal-title":"Biochim. Biophys. Acta"},{"issue":"Jul","key":"3399_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1089\/thy.2010.1635","volume":"20","author":"G Barbesino","year":"2010","unstructured":"G. Barbesino, Drugs affecting thyroid function. Thyroid 20(Jul), 763\u2013770 (2010). https:\/\/doi.org\/10.1089\/thy.2010.1635","journal-title":"Thyroid"},{"issue":"Sep","key":"3399_CR13","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1210\/jc.2007-0586","volume":"92","author":"D Mannavola","year":"2007","unstructured":"D. Mannavola, P. Coco, G. Vannucchi, R. Bertuelli, M. Carletto, P.G. Casali, P. Beck-Peccoz, L. Fugazzola, A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J. Clin. Endocrinol. Metab. 92(Sep), 3531\u20133534 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0586","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Sep-Oct","key":"3399_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.urolonc.2009.08.011","volume":"28","author":"H Miyake","year":"2010","unstructured":"H. Miyake, T. Kurahashi, K. Yamanaka, Y. Kondo, M. Muramaki, A. Takenaka, T.-A. Inoue, M. Fujisawa, Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation. Urol. Oncol. 28(Sep-Oct), 515\u2013519 (2010). https:\/\/doi.org\/10.1016\/j.urolonc.2009.08.011","journal-title":"Urol. Oncol."},{"issue":"Mar","key":"3399_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/jcem.81.3.8772562","volume":"81","author":"C Giani","year":"1996","unstructured":"C. Giani, P. Fierabracci, R. Bonacci, A. Gigliotti, D. Campani, F. De Negri, D. Cecchetti, E. Martino, A. Pinchera, Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J. Clin. Endocrinol. Metab. 81(Mar), 990\u2013994 (1996). https:\/\/doi.org\/10.1210\/jcem.81.3.8772562","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Jan","key":"3399_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bmj.1.6107.210","volume":"1","author":"JG Ratcliffe","year":"1978","unstructured":"J.G. Ratcliffe, B.H. Stack, R.W. Burt, W.A. Radcliffe, W.G. Spilg, J. Cuthbert, R.S. Kennedy, Thyroid function in lung cancer. Br. Med. J. 1(Jan), 210\u2013212 (1978). https:\/\/doi.org\/10.1136\/bmj.1.6107.210","journal-title":"Br. Med. J."},{"issue":"Feb","key":"3399_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2019.00059","volume":"10","author":"E Krashin","year":"2019","unstructured":"E. Krashin, A. Piekie\u0142ko-Witkowska, M. Ellis, O. Ashur-Fabian, Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Front. Endocrinol. (Lausanne) 10(Feb), 59 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00059","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"Jun","key":"3399_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-00566-9","volume":"20","author":"J G\u00f3mez-Izquierdo","year":"2020","unstructured":"J. G\u00f3mez-Izquierdo, K.B. Filion, J.-F.\u04abois Boivin, L. Azoulay, M. Pollak, O.H.Y. Yu, Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review. BMC Endocr. Disord. 20(Jun), 83 (2020). https:\/\/doi.org\/10.1186\/s12902-020-00566-9","journal-title":"BMC Endocr. Disord."},{"issue":"Jun","key":"3399_CR19","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.3390\/jcm11123417","volume":"11","author":"MV Deligiorgi","year":"2022","unstructured":"M.V. Deligiorgi, D.T. Trafalis, The clinical relevance of hypothyroidism in patients with solid non-thyroid cancer: a tantalizing conundrum. J. Clin. Med. 11(Jun), 3417 (2022). https:\/\/doi.org\/10.3390\/jcm11123417","journal-title":"J. Clin. Med."},{"issue":"Nov","key":"3399_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/jnci\/djr373","volume":"103","author":"O-PR Hamnvik","year":"2011","unstructured":"O.-P.R. Hamnvik, P.R. Larsen, E. Marqusee, Thyroid dysfunction from antineoplastic agents. J. Natl Cancer Inst. 103(Nov), 1572\u20131587 (2011). https:\/\/doi.org\/10.1093\/jnci\/djr373","journal-title":"J. Natl Cancer Inst."},{"issue":"Jun","key":"3399_CR21","doi-asserted-by":"publisher","first-page":"e046607","DOI":"10.1136\/bmjopen-2020-046607","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Y. Qiu, Y. Hu, Z. Xing, Q. Fu, J. Zhu, A. Su, Birth control pills and risk of hypothyroidism: a cross-sectional study of the National Health and Nutrition Examination Survey, 2007-2012. BMJ Open 11(Jun), e046607 (2021). https:\/\/doi.org\/10.1136\/bmjopen-2020-046607","journal-title":"BMJ Open"},{"issue":"Jul","key":"3399_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/eje.1.02192","volume":"155","author":"PH Bisschop","year":"2006","unstructured":"P.H. Bisschop, A.W. Toorians, E. Endert, W.M. Wiersinga, L.J. Gooren, Eric Fliers. The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals. Eur. J. Endocrinol. 155(Jul), 11\u201316 (2006). https:\/\/doi.org\/10.1530\/eje.1.02192","journal-title":"Eur. J. Endocrinol."},{"issue":"May","key":"3399_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1210\/js.2017-00057","volume":"1","author":"R Hoermann","year":"2017","unstructured":"R. Hoermann, A.S. Cheung, M. Milne, M. Grossmann, Hypothalamic-pituitary-thyroid axis set point alterations are associated with body composition in androgen-deprived men. J. Endocr. Soc. 1(May), 874\u2013885 (2017). https:\/\/doi.org\/10.1210\/js.2017-00057","journal-title":"J. Endocr. Soc."},{"issue":"Dec","key":"3399_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1507\/endocrj1954.28.785","volume":"28","author":"Y Kajita","year":"1981","unstructured":"Y. Kajita, M. Ishida, T. Hachiya, T. Miyazaki, M. Yoshimura, H. Ijichi, Y. Ochi, Clinical study on increased serum thyroxine-binding globulin in cancerous state. Endocrinol. Jpn 28(Dec), 785\u2013791 (1981). https:\/\/doi.org\/10.1507\/endocrj1954.28.785","journal-title":"Endocrinol. Jpn"},{"issue":"Aug","key":"3399_CR25","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archinte.1981.00340090057014","volume":"141","author":"DP Rose","year":"1981","unstructured":"D.P. Rose, T.E. Davis, Plasma thyronine levels in carcinoma of the breast and colon. Arch. Intern. Med. 141(Aug), 1161\u20131164 (1981)","journal-title":"Arch. Intern. Med."},{"issue":"Oct","key":"3399_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41574-019-0237-z","volume":"15","author":"K Ikegami","year":"2019","unstructured":"K. Ikegami, S. Refetoff, E. Van Cauter, T. Yoshimura, Interconnection between circadian clocks and thyroid function. Nat. Rev. Endocrinol. 15(Oct), 590\u2013600 (2019). https:\/\/doi.org\/10.1038\/s41574-019-0237-z","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Aug","key":"3399_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0933-y","volume":"9","author":"C Gallo","year":"2018","unstructured":"C. Gallo, V. Fragliasso, B. Donati, F. Torricelli, A. Tameni, S. Piana, A. Ciarrocchi, The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1. Cell Death Dis. 9(Aug), 871 (2018). https:\/\/doi.org\/10.1038\/s41419-018-0933-y","journal-title":"Cell Death Dis."},{"key":"3399_CR28","unstructured":"L.J. DeGroot, Graves\u2019 disease and the manifestations of thyrotoxicosis in Endotext, eds. Feingold K.R. et al. (MDText.com, Inc., 2000), p. 1\u201377"},{"issue":"Mar-Apr","key":"3399_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6004\/jadpro.2015.6.2.2","volume":"6","author":"K Hartmann","year":"2015","unstructured":"K. Hartmann, Thyroid disorders in the oncology patient. J. Adv. Pract. Oncol. 6(Mar-Apr), 99\u2013106 (2015). https:\/\/doi.org\/10.6004\/jadpro.2015.6.2.2","journal-title":"J. Adv. Pract. Oncol."},{"issue":"Oct","key":"3399_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1210\/jcem.77.4.8408457","volume":"77","author":"T Nishikawa","year":"1993","unstructured":"T. Nishikawa, S. Yamashita, H. Namba, T. Usa, T. Tominaga, H. Kimura, M. Izumi, S. Nagataki, Interferon-gamma inhibition of human thyrotropin receptor gene expression. J. Clin. Endocrinol. Metab. 77(Oct), 1084\u20131089 (1993). https:\/\/doi.org\/10.1210\/jcem.77.4.8408457","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3399_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/s-2001-11018","volume":"109","author":"P-M Schumm-Draeger","year":"2001","unstructured":"P.-M. Schumm-Draeger, Sodium\/iodide symporter (NIS) and cytokines. Exp. Clin. Endocrinol. Diabetes 109, 32\u201334 (2001). https:\/\/doi.org\/10.1055\/s-2001-11018","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03399-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T03:08:26Z","timestamp":1696043306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03399-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["3399"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03399-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2444292\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}